Insmed Inc (1INSM)
MTA
Real-time Data
07:00 AM
Day's Range
110.3852 wk Range
79.25Overview - 1INSM - Insmed Inc
Key Statistics
Valuation
Enterprise Value
19.91B
P/E (Trailing)
‪-17.19‬
PEG Ratio
‪0.17‬
Price / Sales (TTM)
‪20.86‬
Price / Book
‪36.55‬
EV / EBITDA
‪-29.32‬
Profitability
Gross Margin
‪84.20%‬
Profit Margin
‪-76.94%‬
Operating Margin
‪-23.80%‬
Return on Assets
‪-22.16%‬
Return on Equity
‪-87.21%‬
Ownership
Shares Outstanding
218.28M
Float
216.85M
Held by Insiders
‪0.51%‬
Held by Institutions
‪104.83%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪95.40‬
200-Day Avg
‪122.87‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1INSM - Insmed Inc
Peers - 1INSM - Insmed Inc
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
Profile Summary - 1INSM - Insmed Inc
About
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and inflammation, and neuro and other rare conditions. Insmed’s…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
